Southern Copper (SCCO) to Post Q2 Earnings: What's in Store?

Southern Copper Corporation SCCO is expected to deliver year-over-year improvement in both revenues and earnings when it reports second-quarter 2021 results.

Q1 Results

In the last reported quarter, Southern Copper’s earnings and sales not only beat the Zacks Consensus Estimate but also improved year over year owing to higher prices for copper, silver and zinc.

The company has beat earnings estimates in each of the trailing four quarters, the average surprise being 14.2%.

Southern Copper Corporation Price and EPS Surprise Southern Copper Corporation Price and EPS Surprise

Southern Copper Corporation price-eps-surprise | Southern Copper Corporation Quote

Q2 Estimates

The Zacks Consensus Estimate for second-quarter 2021 earnings per share is currently pegged at $1.09, suggesting an improvement of 220% from the prior-year quarter. The estimate has remained unchanged over the past 30 days. The consensus mark for the quarter’s revenues is pegged at $2.55 billion, suggesting year-over-year growth of 42.6%.

What the Zacks Model Unveils

Our proven model does not predict an earnings beat for Southern Copper this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, this is not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Earnings ESP: The Earnings ESP for Southern Copper is -3.67%.

Zacks Rank: Southern Copper currently carries a Zacks Rank of 3.

Key Factors to Note

Copper represents more than 80% of the company’s sales. Over the past few quarters the company has been witnessing lower production at its Peruvian mines due to lower ore grades and this is expected to continue through 2022. Consequently, the second-quarter production numbers are likely to reflect this impact. This will, however, be somewhat offset by higher production at its Mexican mines and its Mexican underground operations (IMMSA unit) owing to higher production at the San Martin mine.

Overall silver production is likely to be lower on account of lesser production at Buenavista and IMMSA. Production of molybdenum, its main by-product, has been high due of rising production at the Peruvian mines, namely the Toquepala mine after throughput increased at the new Molybdenum plant, spurred by improvements in ore grades and recoveries at other operations. However, this might have been offset by lower production at Buenavista due to lower grades.

Copper prices have gained throughout the second quarter on the back of strong demand from China, while production has been declining in Chile, which is the top producer of the metal. The pickup in global industrial activity has been working in favor of the industrial metal. Average silver prices have been gaining on the back of increase in industrial activity. Zinc prices have gone up in the second quarter on the back of high demand from the steel sector. Higher metal prices might have contributed to the company’s top-line performance in the second quarter and offset the impact of lower production. Operating cash costs are expected to be higher in the to-be-reported quarter due to lower grades. This might get reflected on margins.

Share Price Performance

Zacks Investment Research
Image Source: Zacks Investment Research

The company’s shares have gained 41.9% over the past year compared with the industry’s rally of 73.9%.

Stocks to Consider

Here are some Basic Materials stocks, which you may consider as our model shows that these have the right combination of elements to post an earnings beat in their upcoming releases.

LyondellBasell Industries N.V. LYB has an Earnings ESP of +15.10% and a Zacks Rank of 1, currently. You can see the complete list of today’s Zacks #1 Rank stocks here.

Celanese Corporation CE has a Zacks Rank #2 and an Earnings ESP of +8.38%, at present.

FreeportMcMoRan Inc. FCX, a Zacks #2 Ranked stock, has an Earnings ESP of +0.82%.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Click to get this free report

Southern Copper Corporation (SCCO): Free Stock Analysis Report

FreeportMcMoRan Inc. (FCX): Free Stock Analysis Report

Celanese Corporation (CE): Free Stock Analysis Report

LyondellBasell Industries N.V. (LYB): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics


Latest Stocks Videos


    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

    Learn More